These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16803476)

  • 1. Relationship between p53-associated proteins and estrogen receptor status in ovarian serous neoplasms.
    Cho EY; Choi YL; Chae SW; Sohn JH; Ahn GH
    Int J Gynecol Cancer; 2006; 16(3):1000-6. PubMed ID: 16803476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of p21WAF1/CIP1 and MDM2 characterizes serous borderline ovarian tumors.
    Palazzo JP; Monzon F; Burke M; Hyslop T; Dunton C; Barusevicius A; Capuzzi D; Kovatich AJ
    Hum Pathol; 2000 Jun; 31(6):698-704. PubMed ID: 10872663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDM2 Expression in Serous and Mucinous Epithelial Tumours of the Ovary.
    Abdelaal SE; Habib FM; El Din AA; Gabal SM; Hassan NS; Ibrahim NA
    Asian Pac J Cancer Prev; 2016; 17(7):3295-300. PubMed ID: 27509966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer.
    Agrawal A; Yang J; Murphy RF; Agrawal DK
    Exp Mol Pathol; 2006 Oct; 81(2):115-22. PubMed ID: 16919268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
    Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDM2 mRNA expression in the p53 pathway may predict the potential of invasion and liver metastasis in colorectal cancer.
    Kondo I; Iida S; Takagi Y; Sugihara K
    Dis Colon Rectum; 2008 Sep; 51(9):1395-402. PubMed ID: 18607552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer.
    Wang YC; Lin RK; Tan YH; Chen JT; Chen CY; Wang YC
    J Clin Oncol; 2005 Jan; 23(1):154-64. PubMed ID: 15625370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of CCDC69 activates p14
    Cui L; Zhou F; Chen C; Wang CC
    J Ovarian Res; 2019 Jan; 12(1):4. PubMed ID: 30651135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azidothymidine and cisplatin increase p14ARF expression in OVCAR-3 ovarian cancer cell line.
    Vaskivuo L; Rysä J; Koivuperä J; Myllynen P; Vaskivuo T; Chvalova K; Serpi R; Savolainen ER; Puistola U; Vähäkangas K
    Toxicol Appl Pharmacol; 2006 Oct; 216(1):89-97. PubMed ID: 16797627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical inactivation of p14ARF concomitant with MDM2 overexpression inversely correlates with p53 overexpression in oral squamous cell carcinoma.
    Sano T; Hikino T; Xue Q; Saito T; Kashiwabara K; Oyama T; Nakajima T
    Pathol Int; 2000 Sep; 50(9):709-16. PubMed ID: 11012984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independence of the prognostic value of tumor suppressor protein expression in ovarian adenocarcinomas: A multivariate analysis of expression of p53, retinoblastoma, and related proteins.
    Tachibana M; Watanabe J; Matsushima Y; Nishida K; Kobayashi Y; Fujimura M; Shiromizu K
    Int J Gynecol Cancer; 2003; 13(5):598-606. PubMed ID: 14675342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different expression pattern and significance of p14ARF-Mdm2-p53 pathway and Bmi-1 exist between gastric cardia and distal gastric adenocarcinoma.
    Yao D; Wang Y; Xue L; Wang H; Zhang J; Zhang X
    Hum Pathol; 2013 May; 44(5):844-51. PubMed ID: 23159155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the p14ARF-p53-MDM2 pathway in oral squamous cell carcinoma: MDM2 overexpression is a common event.
    Lim KP; Sharifah H; Lau SH; Teo SH; Cheong SC
    Oncol Rep; 2005 Oct; 14(4):963-8. PubMed ID: 16142358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(adenosine diphosphate-ribose) polymerase expression in serous ovarian carcinoma: correlation with p53, MIB-1, and outcome.
    Brustmann H
    Int J Gynecol Pathol; 2007 Apr; 26(2):147-53. PubMed ID: 17413981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P14ARF deficiency and its correlation with overexpression of p53/MDM2 in sporadic vestibular schwannomas.
    Chen Y; Wang ZY; Wu H
    Eur Arch Otorhinolaryngol; 2015 Sep; 272(9):2227-34. PubMed ID: 24964769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of glucose transporter protein 1 and p63 in serous ovarian tumor.
    Cai Y; Zhai JJ; Feng BB; Duan XZ; He XJ
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1925-30. PubMed ID: 25056472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined analysis of p53 and RB pathways in epithelial ovarian cancer.
    Hashiguchi Y; Tsuda H; Yamamoto K; Inoue T; Ishiko O; Ogita S
    Hum Pathol; 2001 Sep; 32(9):988-96. PubMed ID: 11567230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p14ARF expression in invasive breast cancers and ductal carcinoma in situ--relationships to p53 and Hdm2.
    Vestey SB; Sen C; Calder CJ; Perks CM; Pignatelli M; Winters ZE
    Breast Cancer Res; 2004; 6(5):R571-85. PubMed ID: 15318938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on the spatial architecture of p53, MDM2, and p14ARF containing complexes.
    Savchenko A; Yurchenko M; Snopok B; Kashuba E
    Mol Biotechnol; 2009 Mar; 41(3):270-7. PubMed ID: 18989794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.